The Latest Cardiac and Vascular News
Results show that first-of-its-kind device has a sustained treatment effect and a positive impact on quality of life Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced positive two-year results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. The data show the Philips […]
CHICAGO–(BUSINESS WIRE)–GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence (AI) and digital technology in cardiology and developing new strategies for improved health outcomes. The Consortium […]
Dreamtech distributes Cardea SOLO™ ECG System in Korea through its new healthcare organization iSigNal, and lead commercial expansion in 20+ other APAC countries. BELLEVUE, Wash. & SEONGNAM, South Korea–(BUSINESS WIRE)–Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software announced today that […]
Data show large decreases in atherosclerotic plaque following treatment with epeleuton DUBLIN–(BUSINESS WIRE)–Afimmune, a clinical stage drug discovery company focused on the development of biologically active lipids for the treatment of cardiometabolic diseases, today announced key findings with epeleuton from preclinical atherosclerosis studies. Epeleuton is a next-generation synthetic n-3 fatty […]
– Improvement by two score levels to “A” following the Company’s 2021 ESG Report launch underscores Arena’s long-term commitment to ESG principles PARK CITY, Utah–(BUSINESS WIRE)–Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that as of 2021, Arena received an MSCI ESG Rating of “A.” MSCI ESG Research provides MSCI ESG Ratings […]
Synchron’s flagship StentrodeTM endovascular implant does not require open brain surgery and has obtained FDA Breakthrough Device Designation for the treatment of paralysis The New York based company is already conducting human trials in Australia and is expected to commence a U.S. clinical trial in 2021 NEW YORK–(BUSINESS WIRE)–Synchron, a brain […]
SILVER SPRING, Md., June 3, 2021 /PRNewswire/ — The U.S. Food and Drug Administration is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic’s Heartware Ventricular Assist Device (HVAD) System due to a growing body of observational clinical comparisons that demonstrates a higher frequency of neurological adverse events and […]
In this episode of Investor Insights, Ken Dropiewski sits down with Joe Biller of 3×5 partners to discuss portfolio companies, investment opportunities, and new technologies in the MedTech + Life Sciences space.
– China Grand Pharma will seek regulatory approvals and commercialize CardioFocus’ innovative catheter ablation technology for pulmonary vein isolation – Pulmonary vein isolation is the gold standard treatment for atrial fibrillation MARLBOROUGH, Mass., June 2, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), […]
IRVINE, Calif., June 1, 2021 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff has received U.S. Food and Drug Administration clearance. This is the first noninvasive solution that unlocks Acumen HPI software and uses machine learning to alert clinicians of the […]
